Falandry, C., Rousseau, F., Mouret-Reynier, M., Tinquaut, F., Lorusso, D., Herrstedt, J., . . . Freyer, G. (2021). Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial. JAMA Oncol.
Citación estilo ChicagoFalandry, Claire, et al. "Efficacy and Safety of First-line Single-Agent Carboplatin Vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial." JAMA Oncol 2021.
Cita MLAFalandry, Claire, et al. "Efficacy and Safety of First-line Single-Agent Carboplatin Vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial." JAMA Oncol 2021.